Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Mechanism of malignant hypercalcaemia in carcinoma of the breast.
1985
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
A computerized intervention to improve timing of outpatient follow-up
1994
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Is a more active attitude warranted in patients with subclinical thyrotoxicosis?
1990
Iodine-Induced Hyperthyroidism: Occurrence and Epidemiology
1998
The Thyroid Nodule
2004 Standout
A Model for Planning Optimal Follow-up for Outpatients on Warfarin Anticoagulation
1992
Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy
2002 Standout
Oral Anticoagulant Therapy
2012 Standout
Effects of Computerized Clinical Decision Support Systems on Practitioner Performance and Patient Outcomes
2005 Standout
Cushing's syndrome
2015 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation
2009 Standout
Effects of thyroxin therapy on cardiac function in patients with subclinical hypothyroidism: index of myocardial performance in the evaluation of left ventricular function
2004
Validation of Clinical Classification Schemes for Predicting Stroke
2001 Standout
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.
1993 Standout
A DOUBLE‐BLIND CROSS‐OVER 12‐MONTH STUDY OF l ‐THYROXINE TREATMENT OF WOMEN WITH ‘SUBCLINICAL’ HYPOTHYROIDISM
1988
Chemical models of epilepsy with some reference to their applicability in the development of anticonvulsants
1992
GABAA Receptor Channels
1994 Standout
Serum TSH, T4, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)
2002 Standout
Thyroid Hormone and the Cardiovascular System
2001 Standout
Spectrum of quality of life impairment in hypothyroidism
1994
Subclinical Hypothyroidism and the Risk of Heart Failure, Other Cardiovascular Events, and Death
2005
Subclinical Hyperthyroidism
2001
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
HORMONES AND HYPERTENSION
1989
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Managing Oral Anticoagulant Therapy
2001
Effect of Levothyroxine on Cardiac Function and Structure in Subclinical Hypothyroidism: A Double Blind, Placebo-Controlled Study
2001
A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants
1990
Levothyroxine Replacement Therapy in Central Hypothyroidism: A Practice Report
1999
Oral Anticoagulants
1998
Subclinical Thyroid Disease
2004 Standout
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
Effect of Study Setting on Anticoagulation Control
2006
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
The Use and Misuse of Thyroid Hormone*
1993
Anticoagulation monitoring by an anticoagulation service is more cost-effective than routine physician care
2011
Mechanisms of Bone Metastasis
2004 Standout
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
FINE ADJUSTMENT OF THYROXINE REPLACEMENT DOSAGE: COMPARISON OF THE THYROTROPHIN RELEASING HORMONE TEST USING A SENSITIVE THYROTROPHIN ASSAY WITH MEASUREMENT OF FREE THYROID HORMONES AND CLINICAL ASSESSMENT
1988
Subclinical hypothyroidism and hyperthyroidism. I. Prevalence and clinical relevance
1995
Polymyositis and dermatomyositis
2003 Standout
Thyroid Status, Cardiovascular Risk, and Mortality in Older Adults
2006
Assessment of left ventricular diastolic function by radionuclide ventriculography at rest and exercise in subclinical hypothyroidism, and its response to l-thyroxine therapy
2003
Endogenous Subclinical Hyperthyroidism Affects Quality of Life and Cardiac Morphology and Function in Young and Middle-Aged Patients*
2000
Subclinical Hypothyroidism in a Biethnic, Urban Community
1999
Subclinical thyroid disease
1996
Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation
2004
Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association
2012
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
Epidemiology and Prevention of Clinical and Subclinical Hypothyroidism
2002
Cardiovascular Hemodynamics and Exercise Tolerance in Thyroid Disease
2002
Cardiovascular and Atherogenic Aspects of Subclinical Hypothyroidism
2000
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
Engineering Adolescence
2014 Standout
Effect of Thyroxine Therapy on Serum Lipoproteins in Patients with Mild Thyroid Failure: A Quantitative Review of the Literature*
2000
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
The Influence of Cannabidiol and Δ9‐Tetrahydrocannabinol on Cobalt Epilepsy in Rats
1979
Randomized prospective trial comparing the native prothrombin antigen with the prothrombin time for monitoring oral anticoagulant therapy
1990
Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases
2002 Standout
Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine.
1993
Effect of Thyroxine Therapy on Serum Lipoproteins in Patients with Mild Thyroid Failure: A Quantitative Review of the Literature
2000
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
2001 Standout
Left Ventricular Diastolic Dysfunction in Patients with Subclinical Hypothyroidism
1999
The Clinical Significance of Subclinical Thyroid Dysfunction
2007
Guidelines for the Primary Prevention of Stroke
2014 Standout
Antithrombotic Therapy in Atrial Fibrillation
1989
Systematic Review: Impact of Health Information Technology on Quality, Efficiency, and Costs of Medical Care
2006 Standout
The Secondary Prevention of Stroke in Patients With Atrial Fibrillation
1986
Treatment Guidelines for Patients With Hyperthyroidism and Hypothyroidism
1995 Standout
Acute Effects of Propylthiouracil (PTU) on Thyroidal Iodide Organification and Peripheral Iodothyronine Deiodination: Correlation with Serum PTU Levels Measured by Radioimmunoassay*
1982
Initiation of warfarin therapy
1987
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Abnormal Left Ventricular Function in Hyperthyroidism
1982
Anticoagulation Management as a Risk Factor for Adverse Events: Grounds for Improvement
1998
Anticoagulation in Atrial Fibrillation
1994
Subclinical thyroid disease
1996
Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
1993 Standout
Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats
1982
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial.
2003
Subclinical Hypothyroidism in Older Persons
1995
Effects of Subclinical Thyroid Dysfunction on the Heart
2002
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Acute Hemodynamic Effects of Levothyroxine Loading in Critically Ill Hypothyroid Patients
1986
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2012 Standout
The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation
1990 Standout
Adverse Effects of Drugs on Muscle
1982
Evaluation and Management of the Solid Thyroid Nodule
1995
Works of J.C. Forfar being referenced
Proximal myopathy during beta-blockade.
1979
THE EFFECT OF MINOR INCREMENTS IN PLASMA THYROXINE ON HEART RATE AND URINARY SODIUM EXCRETION
1983
Paracetamol pharmacokinetics in thyroid disease
1980
Atrial fibrillation and isolated suppression of the pituitary-thyroid axis: response to specific antithyroid therapy
1981
The Effects of Some Anticonvulsant Drugs on Cobalt‐induced Epilepsy
1973
Prediction of hemorrhage during long-term oral coumarin anticoagulation by excessive prothrombin ratio
1982
Left Ventricular Performance in Subclinical Hypothyroidism
1985
CARDIOVASCULAR RESPONSES IN HYPERTHYROIDISM BEFORE AND DURING 0‐ADRENOCEPTOR BLOCKADE: EVIDENCE AGAINST ADRENERGIC HYPERSENSITIVITY
1982
END‐ORGAN RESPONSES TO THYROXINE THERAPY IN SUBCLINICAL HYPOTHYROIDISM
1985
Left ventricular function in hypothyroidism. Responses to exercise and beta adrenoceptor blockade.
1982